Cargando…

Distinct features of dendritic cell-based immunotherapy as cancer vaccines

Dendritic cells (DCs) are the most professional antigen presenting cells that play important roles in connection between innate and adaptive immune responses. Numerous studies revealed that the functions of DCs are related with the capture and processing of antigen as well as the migration to lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chaelin, Lee, Myungmi, Rhee, Inmoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795041/
https://www.ncbi.nlm.nih.gov/pubmed/29399576
http://dx.doi.org/10.7774/cevr.2018.7.1.16
_version_ 1783297223202701312
author Lee, Chaelin
Lee, Myungmi
Rhee, Inmoo
author_facet Lee, Chaelin
Lee, Myungmi
Rhee, Inmoo
author_sort Lee, Chaelin
collection PubMed
description Dendritic cells (DCs) are the most professional antigen presenting cells that play important roles in connection between innate and adaptive immune responses. Numerous studies revealed that the functions of DCs are related with the capture and processing of antigen as well as the migration to lymphoid tissues for the presenting antigens to T cells. These unique features of DCs allow them to be considered as therapeutic vaccines that can induce immune responses and anti-tumor activity. Here, we discuss and understand the immunological basis of DCs and presume the possibilities of DC-based vaccines for the promising cancer therapy.
format Online
Article
Text
id pubmed-5795041
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Vaccine Society
record_format MEDLINE/PubMed
spelling pubmed-57950412018-02-02 Distinct features of dendritic cell-based immunotherapy as cancer vaccines Lee, Chaelin Lee, Myungmi Rhee, Inmoo Clin Exp Vaccine Res Review Article Dendritic cells (DCs) are the most professional antigen presenting cells that play important roles in connection between innate and adaptive immune responses. Numerous studies revealed that the functions of DCs are related with the capture and processing of antigen as well as the migration to lymphoid tissues for the presenting antigens to T cells. These unique features of DCs allow them to be considered as therapeutic vaccines that can induce immune responses and anti-tumor activity. Here, we discuss and understand the immunological basis of DCs and presume the possibilities of DC-based vaccines for the promising cancer therapy. The Korean Vaccine Society 2018-01 2018-01-29 /pmc/articles/PMC5795041/ /pubmed/29399576 http://dx.doi.org/10.7774/cevr.2018.7.1.16 Text en © Korean Vaccine Society. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Lee, Chaelin
Lee, Myungmi
Rhee, Inmoo
Distinct features of dendritic cell-based immunotherapy as cancer vaccines
title Distinct features of dendritic cell-based immunotherapy as cancer vaccines
title_full Distinct features of dendritic cell-based immunotherapy as cancer vaccines
title_fullStr Distinct features of dendritic cell-based immunotherapy as cancer vaccines
title_full_unstemmed Distinct features of dendritic cell-based immunotherapy as cancer vaccines
title_short Distinct features of dendritic cell-based immunotherapy as cancer vaccines
title_sort distinct features of dendritic cell-based immunotherapy as cancer vaccines
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795041/
https://www.ncbi.nlm.nih.gov/pubmed/29399576
http://dx.doi.org/10.7774/cevr.2018.7.1.16
work_keys_str_mv AT leechaelin distinctfeaturesofdendriticcellbasedimmunotherapyascancervaccines
AT leemyungmi distinctfeaturesofdendriticcellbasedimmunotherapyascancervaccines
AT rheeinmoo distinctfeaturesofdendriticcellbasedimmunotherapyascancervaccines